Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively

Journal of Translational Medicine

Volumn 14, Issue 1, 2016, Pages

  Huang, Biao ^a   Cheng, Xixi ^a   Wang, Huafeng ^a,b   Huang, Wenjing ^a   Ga hu, Zha ^c   Wang, Dan ^a   Zhang, Kai ^a   Zhang, Huan ^a   Xue, Zhenyi ^a   Da, Yurong ^a   Zhang, Ning ^a   Hu, Yongcheng ^d   Yao, Zhi ^a   Qiao, Liang ^e   Gao, Fei ^f   Zhang, Rongxin ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b SHANXI NORMAL UNIVERSITY   (China)

^c Logistics University   (China)

^d TIANJIN HOSPITAL   (China)

^e UNIVERSITY OF SYDNEY   (Australia)

^f INSTITUTE OF ZOOLOGY   (China)

Author keywords

CD4+ T cells; Hepatic stellate cells; Liver failure; Macrophages; MSC CM

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL DEATH; CELL PROLIFERATION; CELL TRANSPLANTATION; CONTROLLED STUDY; DOWN REGULATION; EXTRAVASATION; FEMALE; FIBROGENESIS; FULMINANT HEPATIC FAILURE; GLYCOGEN SYNTHESIS; IN VITRO STUDY; LIVER CELL; LIVER FIBROSIS; LIVER REGENERATION; MACROPHAGE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL CONDITIONED MEDIUM; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; REGULATORY T LYMPHOCYTE; STELLATE CELL; TH17 CELL; TH2 CELL; ANIMAL; C57BL MOUSE; CHRONIC DISEASE; COMPLICATION; CONDITIONED MEDIUM; CYTOLOGY; DRUG EFFECTS; HEPATIC STELLATE CELL; INFLAMMATION; INSTITUTE FOR CANCER RESEARCH MOUSE; LIVER; LIVER CIRRHOSIS; LIVER FAILURE, ACUTE; MESENCHYMAL STROMA CELL; PATHOLOGY; PHARMACOLOGY; RAW 264.7 CELL LINE; REGENERATION; SECRETION (PROCESS); SURVIVAL ANALYSIS;

CARBON TETRACHLORIDE; CONDITIONED MEDIUM;

ANIMALS; APOPTOSIS; CARBON TETRACHLORIDE; CELL PROLIFERATION; CHRONIC DISEASE; CULTURE MEDIA, CONDITIONED; DOWN-REGULATION; FEMALE; HEPATIC STELLATE CELLS; INFLAMMATION; LIVER; LIVER CIRRHOSIS; LIVER FAILURE, ACUTE; MACROPHAGES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; RAW 264.7 CELLS; REGENERATION; SURVIVAL ANALYSIS;

EID: 84960097542     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-016-0792-1     Document Type: Article

References (31)

1. Sass DA, Shakil AO. Fulminant hepatic failure. Liver Transpl. 2005;11:594-605.
2. Petersen B, et al. Bone marrow as a potential source of hepatic oval cells. Science. 1999;284:1168-70.
3. Gilchrist ES, Plevris JN. Bone marrow-derived stem cells in liver repair: 10years down the line. Liver Transpl. 2010;16:118-29.
4. Pan RL, Wang P, Xiang LX, Shao JZ. Delta-like 1 serves as a new target and contributor to liver fibrosis down-regulated by mesenchymal stem cell transplantation. J Biol Chem. 2011;286:12340-8.
5. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8:726-36.
6. da Silva Meirelles L, Fontes AM, Covas DT, Caplan AI. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 2009;20:419-27.
7. Uccelli A, Prockop DJ. Why should mesenchymal stem cells (MSCs) cure autoimmune diseases? Curr Opin Immunol. 2010;22:768-74.
8. MacDonald GI, Augello A, De Bari C. Role of mesenchymal stem cells in reestablishing immunologic tolerance in autoimmune rheumatic diseases. Arthritis Rheum. 2011;63:2547-57.
9. Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN, Papamichail M. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells. 2006;24:74-85.
10. Akiyama K, et al. Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. Cell Stem Cell. 2012;10:544-55.
11. Wang L, Zhao Y, Shi S. Interplay between mesenchymal stem cells and lymphocytes implications for immunotherapy and tissue regeneration. J Dent Res. 2012;91:1003-10.
12. English K. Mechanisms of mesenchymal stromal cell immunomodulation. Immunol Cell Biol. 2012;91:19-26.
13. Zhu H, et al. A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat Protoc. 2010;5:550-60.
14. van Poll D, et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology. 2008;47:1634-43.
15. Meier RP, Muller YD, Morel P, Gonelle-Gispert C, Bühler LH. Transplantation of mesenchymal stem cells for the treatment of liver diseases, is there enough evidence? Stem Cell Res. 2013;11(3):1348-64.
16. Lavoie JR, Rosu-Myles M. Uncovering the secretes of mesenchymal stem cells. Biochimie. 2013;95(12):2212-21.
17. Maggini J, et al. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One. 2010;5:e9252.
18. Prockop DJ, Oh JY. Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther. 2011;20:14-20.
19. Gupta N, et al. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol. 2007;179:1855-63.
20. Jansen BJ, et al. Functional differences between mesenchymal stem cell populations are reflected by their transcriptome. Stem Cells Dev. 2010;19:481-90.
21. Bai L, et al. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia. 2009;57:1192-203.
22. Bai L, et al. Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat Neurosci. 2012;15:862-70.
23. Rafei M, Birman E, Forner K, Galipeau J. Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis. Mol Ther. 2009;17:1799-803.
24. Mantovani A, et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25:677-86.
25. Kisseleva T, et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci. 2012;109:9448-53.
26. Parekkadan B, et al. Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells. Biochem Biophys Res Commun. 2007;363:247-52.
27. Carvalho AB, et al. Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury. Stem Cells. 2008;26:1307-14.
28. Li C, et al. Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. J Hepatol. 2009;50:1174-83.
29. Russo FP, et al. The bone marrow functionally contributes to liver fibrosis. Gastroenterology. 2006;130:1807-21.
30. Kallis YN, Forbes SJ. The bone marrow and liver fibrosis: friend or foe? Gastroenterology. 2009;137:1218-21.
31. Ishak K, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696-9.